Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1

• Guangyuan Li,

  Affiliations Department of Pathology, University Hospitals of Case Medical Center, Case Western Reserve University, Cleveland, Ohio, United States of America, Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Xiaoqi Wang,

  Affiliation Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Hanina Hibshoosh,

  Affiliation Department of Pathology, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Cheng Jin,

  Affiliation Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Balazs Halmos

  * E-mail: bh2376@columbia.edu

  Affiliation Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, United States of America

  ⨯